Awardee OrganizationVETERANS AFFAIRS MED CTR SAN FRANCISCO
Description
Abstract Text
Dr. Ford is an established investigator in neuroscience and psychiatry, with a PhD in neuroscience and life-long
appointments in mental health/psychiatry. She uses electroencephalography (EEG) and functional magnetic
resonance imaging (fMRI), to investigate the neurobiology of schizophrenia (SZ) and major depressive disorder
(MDD). And now, she is adding COVID19 “long haulers” to the conditions she studies with brain imaging
methods.
SZ. Dr. Ford’s work in SZ was focused on an elemental neural system that dampens neural responses to self-
generated stimuli compared to stimuli arising from the environment. It is thought to reflect the operation of an
efference copy/corollary discharge mechanism involving signaling from motor to sensory regions, preparing
sensory regions for self-generated sensory events. This mechanism is ubiquitous across all animal species, and
her work in translating this mechanism to a human paradigm has uncovered a fundamental deficit in sensory
information processing in people on the psychosis spectrum. With NIH R01 funding, she has shown deficiencies
in these mechanisms are linked to auditory hallucinations and delusions. With current NIH R03 funding, she is
now asking about the role of the thalamo-pontine-cerebellar circuit in the successful operation of this system.
Two of Dr. Ford’s VA trainees are now extending this work to a new sample of people with psychosis, their 1st
degree relatives, youth at clinical risk for developing psychosis, and non-affected control participants. They are
finding connectivity between cerebellum and pons is related to the action of the efference copy/corollary
discharge mechanism. With a more recently funded NIH R03 grant, she is asking whether EEG-assessed
slowed perception has upstream effects on cognition and contributes to clinical features of psychosis in the
schizophrenia spectrum. With a to-be-funded mechanistic clinical trial (NIH R21) involving a VA psychiatrist, a
VA radiologist, and a UCSF cardiologist, she is asking whether a ketogenic diet can restore neural network
stability in SZ, thereby addressing both cognitive deficits and metabolic syndrome, associated with poor function
and a shortened life span, respectively.
MDD/SZ. About 4 years ago, she added MDD to the clinical populations she studies and is asking about the
negative consequences of rumination and whether they can be rescued by a mindfulness approach to life.
Rumination is an internal cognitive state characterized by recursive thinking of self-distress and negative events
focusing on the causes and consequences of distress rather than solutions. It cuts across diagnostic boundaries:
It is associated with symptom severity and chronicity in both MDD and SZ. Mindfulness is associated with less
distress from auditory hallucinations in SZ and fewer residual symptoms in MDD. It involves attending to present
moment experiences and sensations and allowing emotions and thoughts to enter and leave consciousness
without judgment, thereby avoiding a downward spiral into rumination. Compared to simple mind wandering,
mindfulness recruits an attention network including parietal and prefrontal structures while mind wandering only
recruits the default mode network.
Long-COVID19. The newest population she is studying is the so-called ‘long-haulers’ following COVID19
infection. While the lungs are ground zero, COVID19 tears through organ systems from brain to blood vessels.
Some who recover complain of ongoing problems, including lingering cognitive problems, depression, and
anxiety. Dr. Ford has joined forces with both Lab Medicine and Radiology at SFVAMC to use psychological
testing, neuroimaging methods, and markers in the blood signaling damage in the brain. A close look at these
problems is timely and imperative if we are to understand the pathophysiology of “COVID brain” and prepare for
down-stream problems.
Public Health Relevance Statement
Dr. Ford uses brain imaging to ask questions about brain-related conditions—schizophrenia, major
depressive disorder, and COVID19 “long hauler” syndrome, which now qualifies as a disability. The clinical
significance of Dr. Ford’s work is broad, from hallucinations and delusions, which are associated with high
morbidity and mortality, to the harmful and mitigating effects of rumination and mindfulness, to understanding
the long-term effects of COVID19 on the brain. We are quickly learning that pre-existing conditions that
characterize Veterans--smoking, obesity, high blood pressure, asthma, cancer--confer a higher risk of
complications from COVID19. The cost is high to VA, society, and the patients and families suffering from these
conditions. Understanding their pathophysiology may ultimately relieve suffering.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdvocateAmericanAnesthesiologyAnimalsAnxietyAppointmentAsthmaAttentionAuditoryAuditory HallucinationAwardBehaviorBehavioral SciencesBiological PsychiatryBloodBlood VesselsBody SystemBrainBrain imagingCOVID-19COVID-19 complicationsCOVID-19 impactCOVID-19 long haulerCOVID-19 survivorsCerebellumChronicClinicalClinical MedicineClinical TrialsCognitionCognitiveCognitive deficitsCollaborationsCongressesConsciousDelusionsDiagnosticDietDistressDoctor of PhilosophyEducational process of instructingElectroencephalographyElementsEmotionsEnvironmentEsthesiaEventFamilyFirst Degree RelativeFoundationsFunctional Magnetic Resonance ImagingFunctional disorderFundingGrantGroup MeetingsHallucinationsHumanHypertensionInternationalJudgmentKetonesLeadershipLearningLifeLinkLongCOVIDLungMagnetic Resonance ImagingMajor Depressive DisorderMalignant NeoplasmsMedicineMental DepressionMental HealthMentorsMetabolic syndromeMethodsMindMindfulness TrainingMorbidity - disease rateMotorNeurobiologyNeurosciencesObesityParietalParticipantPatientsPerceptionPersonsPhasePhysiciansPontine structurePopulationPsychiatristPsychiatryPsychological TestsPsychologistPsychosesQualifyingRadiologic HealthRadiology SpecialtyResearchResearch PersonnelResidual stateReview CommitteeRoleSamplingSchizophreniaScientistSensorySeveritiesSignal TransductionSmokingSocietiesStimulusStructureSymptomsSystemTalentsThinkingTranslatingUnited States National Institutes of HealthVeteransWorkYouthbiomarker identificationcareerclinical riskclinically significantcollegecostdeficit syndromedisabilityeditorialexperiencefunctional magnetic resonance imaging/electroencephalographyhigh riskimaging modalityinformation processingketogenic dietlife spanlong-term consequences of COVID-19meetingsmembermindfulnessmortalityneuralneural networkneuroimagingneuropsychopharmacologyoperationpost SARS-CoV-2 infectionprogramsradiologistrecruitresponseruminationschizophrenia spectrum disordervirtual
No Sub Projects information available for 5IK6CX002519-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5IK6CX002519-03
Patents
No Patents information available for 5IK6CX002519-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5IK6CX002519-03
Clinical Studies
No Clinical Studies information available for 5IK6CX002519-03
News and More
Related News Releases
No news release information available for 5IK6CX002519-03
History
No Historical information available for 5IK6CX002519-03
Similar Projects
No Similar Projects information available for 5IK6CX002519-03